Eric Padron
Impact in
- Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Virus-based gene therapy research
Papers in
- Hematology 296
- Acute Myeloid Leukemia Research 292
- Chronic Myeloid Leukemia Treatments 8
- Hematopoietic Stem Cell Transplantation 7
- Platelet Disorders and Treatments 5
- Genetics 44
- Myeloproliferative Neoplasms: Diagnosis and Treatment 40
- Virus-based gene therapy research 5
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Rami S. Komrokji (207 shared papers)Alan F. List (139 shared papers)Jeffrey E. Lancet (158 shared papers)David Andrew Sallman (123 shared papers)Najla E. Al Ali (75 shared papers)Najla H. Al Ali (54 shared papers)Robert McKenna (6 shared papers)Mavis Agbandje‐McKenna (6 shared papers)
- Journals
- Blood (111 papers)Leukemia (26 papers)Leukemia Research (18 papers)Blood Advances (16 papers)American Journal of Hematology (14 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Eric Padron
330 papers receiving 11.4k citations
Eric Padron's Hit Papers
Peers
Comparison fields: 5 of 109
- Hematology 7.5k
- Genetics 1.4k
- Cancer Research 398
- Oncology 646
- Genetics 763
Countries citing papers authored by Eric Padron
This map shows the geographic impact of Eric Padron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Padron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Padron more than expected).
Fields of papers citing papers by Eric Padron
This network shows the impact of papers produced by Eric Padron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Padron. The network helps show where Eric Padron may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Padron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 355 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms Hit paper breakdown → | 2022 | 2613 |
| 2 | Cancer therapy shapes the fitness landscape of clonal hematopoiesis Hit paper breakdown → | 2020 | 559 |
| 3 | 2018 | 416 | |
| 4 | Eprenetapopt (APR-246) and Azacitidine in TP53 -Mutant Myelodysplastic Syndromes Hit paper breakdown → | 2021 | 387 |
| 5 | 2016 | 302 | |
| 6 | 2016 | 263 | |
| 7 | 2007 | 216 | |
| 8 | 2019 | 197 | |
| 9 | 2015 | 194 | |
| 10 | 2013 | 185 | |
| 11 | 2016 | 182 | |
| 12 | 2006 | 178 | |
| 13 | 2020 | 156 | |
| 14 | 2015 | 153 | |
| 15 | 2013 | 134 | |
| 16 | 2017 | 125 | |
| 17 | 2015 | 120 | |
| 18 | 2017 | 117 | |
| 19 | 2016 | 111 | |
| 20 | 2019 | 105 |
About Eric Padron
Eric Padron is a scholar working on Hematology, Genetics, Oncology, Immunology and Molecular Biology, having authored 355 papers that have together received 11.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (292 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (40 papers), Inflammasome and immune disorders (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Hematopoietic Stem Cell Transplantation (7 papers), Virus-based gene therapy research (5 papers), Platelet Disorders and Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (7.5k citations), Genetics (1.4k citations), Cancer Research (398 citations), Oncology (646 citations) and Genetics (763 citations). Eric Padron has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Rami S. Komrokji, Alan F. List, Jeffrey E. Lancet, David Andrew Sallman, Najla E. Al Ali, Najla H. Al Ali, Robert McKenna, Mavis Agbandje‐McKenna, Kendra Lynn Sweet and Nicholas Muzyczka. Their work appears in journals such as Blood, Leukemia, Leukemia Research, Blood Advances and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.